Vaxart News | finanzen.ch

Kurse + Charts + Realtime	News + Analysen	Fundamental	Unternehmen	zugeh. Wertpapiere	Aktion
Kurs + Chart	Chart (gross)	News + Adhoc	Bilanz/GuV	Termine	Strukturierte Produkte	Portfolio
Times + Sales	Chartvergleich	Analysen	Schätzungen	Profil		Watchlist
Börsenplätze	Realtime Push	Kursziele	Dividende/GV
Historisch			Analysen

Kurse + Charts + Realtime

News + Analysen

Fundamental

Unternehmen

zugeh. Wertpapiere

Aktion

Kurs + Chart

Chart (gross)

News + Adhoc

Bilanz/GuV

Termine

Strukturierte Produkte

Portfolio

Times + Sales

Chartvergleich

Analysen

Schätzungen

Profil

Watchlist

Börsenplätze

Realtime Push

Kursziele

Dividende/GV

Historisch

Analysen

28.08.24	Vaxart's Pre-clinical Data Reveals Potential Of Mucosal Vaccine Platform For HPV- Cervical Dysplasia (RTTNews)
14.06.24	Vaxart Announces Underwritten Offering Of 50 Mln Shares At $0.80/shr (RTTNews)
06.07.23	Vaxart Announces Positive Preliminary Topline Data Of Its Bivalent Norovirus Vaccine Candidate (RTTNews)
31.10.22	Scott+Scott Attorneys at Law LLP and Hagens Berman Sobol Shapiro LLP Announce Pendency of Class Action To All Persons and Entities Who Purchased or Otherwise Acquired Shares of the Common Stock of... (PR Newswire)
01.09.22	Vaxart: Phase II Study Of Wuhan S-only Oral Pill COVID-19 Vaccine Candidate Meets Endpoints (RTTNews)
27.07.22	Vaxart gibt neues Update zur Stimmrechtsvertretung und fordert alle am 11. April 2022 eingetragenen Aktionäre auf, bis zum 3. August 2022 um 23:59 Uhr ET abzustimmen (GlobeNewswire)
27.07.22	Vaxart Provides New Update on Proxy Voting and Urges All Stockholders of Record as of April 11, 2022, to Vote by August 3, 2022, at 11:59 p.m. ET (GlobeNewswire)
02.05.22	Pre-market Movers: SOUN, BIOL, QMCO, FATH, VXRT… (RTTNews)
26.10.21	Vaxart Doses First Subject in Phase II COVID-19 Oral Tablet Vaccine Clinical Trial (PR Newswire)
08.10.21	Pre-market Movers: MIC, ALLO, EFTR, CEI, SNDL… (RTTNews)
07.10.21	Vaxart Jumps 12% On Positive Data From Oral Covid-19 Vaccine Study (RTTNews)
07.10.21	New Duke University-led Study Shows That Vaxart's Oral COVID-19 Vaccine Candidate Reduces Airborne Transmission of SARS-CoV-2 Infection in Animal Model (PR Newswire)
06.10.21	Vaxart To Begin US Phase II Trial Of S-Only Vaccine Candidate - Quick Facts (RTTNews)
06.10.21	Vaxart Begins Recruiting in Global Phase II COVID-19 Oral Tablet Vaccine Clinical Trial (PR Newswire)
27.09.21	Vaxart Appoints Dr. James F. Cummings as Chief Medical Officer (PR Newswire)
22.09.21	Vaxart To Present at Upcoming Vaccine Conferences (PR Newswire)
21.09.21	Vaxart Announces Creation of Manufacturing and Quality Advisory Board (PR Newswire)
20.09.21	Vaxart to Present at the 2021 Cantor Virtual Global Healthcare Conference on Thursday, September 30 (PR Newswire)
07.09.21	Vaxart to Present at the H.C. Wainwright 23rd Annual Global Investment Conference (PR Newswire)
23.08.21	Vaxart Announces Highly Regarded Biotech Executive Julie M. Cherrington, Ph.D., Joins Board of Directors (PR Newswire)
19.08.21	Vaxart Announces Creation of New Scientific and Clinical Advisory Board (PR Newswire)
05.08.21	Vaxart Provides Business Update and Reports Second Quarter 2021 Financial Results (PR Newswire)
02.08.21	FDA OKs Vaxart's IND Application For S-Only Oral Tablet SARS-CoV-2 Vaccine Candidate - Quick Facts (RTTNews)
02.08.21	FDA Clears Vaxart's IND Application for S-Only Oral Tablet COVID-19 Vaccine Candidate (PR Newswire)
29.07.21	Vaxart's Booster Study Of Oral Norovirus Vaccine Yields Encouraging Immune Responses (RTTNews)
29.07.21	Vaxart Reports Boosting Immune Responses in Subjects Previously Vaccinated by a Vaxart Vaccine (PR Newswire)
07.07.21	Vaxart Rises 3% After Signing License Agreement With Altesa Biosciences (RTTNews)
22.04.21	Had It Been Covid-19 Oral Pill, More Americans Would Have Opted For Vaccination: Poll (RTTNews)
04.02.21	BIIB Pulls Plug On Parkinson's Drug, JAZZ Acquires GWPH, NBIX Ends Deal With VYGR, TYME Flies (RTTNews)
03.02.21	SAVA Jumps From $7 To $75 In Just 3 Weeks, DRRX Gets FDA Nod, IMVT Pauses Trials, OCGN Catches Eye (RTTNews)
31.01.21	Week Ahead In Pharma: Data Readouts Of COVID-19 Trials & FDA Decisions (RTTNews)
27.01.21	AGIO's ACTIVATE-T Hits Goals, EDSA Catches Eye, JNJ Provides Rosy Outlook, VXRT On Watch (RTTNews)
26.01.21	AZN Rejects Media Reports, MRK Quits COVID-19 Vaccine Work, MRNA Sets Eyes On New SARS-CoV-2 Strains (RTTNews)
25.11.20	Pre-market Movers In Healthcare Sector: COCP, ADXS, VXRT, HEPA… (RTTNews)
17.11.20	Pre-market Movers In Healthcare Sector: LXRX, NEPT, VXRT, BNTX, CVAC… (RTTNews)
27.10.20	Pre-market Movers In Healthcare Sector: ALKS, ETTX, VXRT, CATB, GNFT... (RTTNews)
13.10.20	Stock Alert: Vaxart Up 14% After Dosing First Patient In Oral COVID-19 Vaccine Trial (RTTNews)
07.10.20	Kindred Expands Manufacturing Deal With Vaxart For COVID-19 And Other Vaccine Candidates (RTTNews)
05.10.20	Pre-market Movers In Healthcare Sector: ENLV, CHFS, EVGN, SLDB, CTIC, VXRT… (RTTNews)
02.10.20	Pre-market Movers In Healthcare Sector: XTNT, NNOX, VXRT, INO, MESO… (RTTNews)
21.09.20	Pre-market Movers In Healthcare Sector: ONTX, ACST, VXRT, CMPS, LPCN... (RTTNews)
17.09.20	Pre-market Movers In Healthcare Sector: SRNE, GNCA, VXRT, BNTX, INO... (RTTNews)
16.09.20	ARPO To Report Glaucoma Trial Data In Q4, ARDX To Face FDA In April, PFE's Pipeline Update (RTTNews)
15.09.20	Pre-market Movers In Healthcare Sector: NVUS, MRNS, ABIO, LPCN, CLRB, VXRT… (RTTNews)
14.09.20	Stock Alert: Vaxart Jumps 20% On Permission To Start Human Trials Of Covid-19 Vaccine (RTTNews)
14.09.20	Vaxart Says FDA Clears IND Application For Oral COVID-19 Vaccine - Quick Facts (RTTNews)
14.09.20	Pre-market Movers In Healthcare Sector: IMMU, SAVA, DVAX, ENLV, VXRT... (RTTNews)
09.09.20	Pre-market Movers In Healthcare Sector: TRIL, AERI, NVAX, VXRT, MRNA… (RTTNews)
25.08.20	Pre-market Movers In Healthcare Sector: OCGN, CERS, IBIO, KMDA, SONN… (RTTNews)
15.08.20	4 Stocks That Delivered Over 1,000% Returns (RTTNews)

Aktien Top/Flop

SMI
SPI
SLI
SMIM
DAX
ESTOXX
Dow Jones
S&P 500
NASDAQ 100
Nikkei 225

Sonova Hldg	295.60	0.96 %	K V
Lonza Grp	531.00	0.53 %	K V
Alcon	76.02	0.34 %	K V
Roche Hldg G	247.40	0.28 %	K V
ABB	48.86	0.27 %	K V
Swisscom	498.40	-0.62 %	K V
UBS Group	26.71	-0.67 %	K V
Zurich Insur Gr	533.00	-0.97 %	K V
Holcim	86.10	-1.01 %	K V
Sika	213.20	-2.47 %	K V

mehr

Portfolioname Watchlistname
Portfolio
Name
Typ
Valor / ISIN
Börse
Anzahl
Aktueller Kurs
Kurszeit
Kaufpreis
Kaufdatum
Kaufwert	CHF
	Hinzufügen Speichern

Nachrichten zu Vaxart Inc Registered Shs

Aktien Top/Flop

Meistgelesene Nachrichten